Роль микроокружения в развитии и прогрессии рака поджелудочной железы

Автор: Окладникова Евгения Владимировна, Рукша Татьяна Геннадьевна

Журнал: Сибирский онкологический журнал @siboncoj

Статья в выпуске: 3 (75), 2016 года.

Бесплатный доступ

Рак поджелудочной железы обладает быстрым инвазивным ростом, ранней склонностью к метастазированию и плохо поддается химиотерапии. Ипользование таргетных препаратов пока не позволило добиться значительных успехов в борьбе с раком поджелудочной железы. Одним из перспективных направлений молекулярной онкологии последних лет является изучение микроокружения опухоли для осуществления целенаправленного воздействия. В представленном обзоре обсуждаются морфофункциональные особенности микроокружения опухоли поджелудочной железы, а также механизмы межклеточных коммуникаций. Изучение данной темы актуально для разработки новых методов терапии рака поджелудочной железы.

Еще

Рак поджелудочной железы, микроокружение опухоли

Короткий адрес: https://sciup.org/140253943

IDR: 140253943 | DOI: 10.21294/1814-4861-2016-15-3-82-90

Список литературы Роль микроокружения в развитии и прогрессии рака поджелудочной железы

Ельникова А.А. Микроокружение опухоли -темная лошадка в противоопухолевой химиотерапии//Здоровье и образование в XXI веке. 2015. Т. 17, № 1. С. 84-86
Монастырская Е.А., Лямина С.В., Малышев И.Ю. М1 и М2 фенотипы активированных макрофагов и их роль в иммунном ответе и патологии//Патогенез. 2008. Т. 6, № 4. С. 31-39
Состояние онкологической помощи населению России в 2013 году/Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой. М., 2014. 235 с
AlachkarH.,SanthanamR.,MaharryK.,Metzeler K.H.,HuangX.,Kohlschmidt J., Mendler J.H., Benito J.M., Hickey C., Neviani P., Dorrance A.M., Anghelina M., Khalife J., Tarighat S.S.,Volinia S., Whitman S.P., Paschka P., Hoellerbauer P., Wu Y.Z., Han L., Bolon B.N., BlumW., Mrózek K., Car-roll A.J., Perrotti D., Andreeff M., Caligiuri M.A., Konopleva M., Garzon R., Bloomfield C.D, Marcucci G. SPARC promotes leukemic cell growth and predicts acute myeloid leukemia outcome//J. Clin. Invest. 2014. Vol. 124 (4). P. 1512-1524 DOI: 10.1172/JCI70921
Apte M.V., Pirola R.C., Wilson J.S. The fibrosis of chronic pancreatitis: new insights into the role of pancreatic stellate cells//Antioxid. Redox. Signal. 2011. Vol. 15 (10). P. 2711-2722 DOI: 10.1089/ars.2011.4079
Apte M.V., Xu Z., Pothula S., Goldstein D., Pirola R.C., Wilson J.S. Pancreatic cancer: The microenvironment needs attention too!//Pancreatology. 2015. Vol. 15 (4 Suppl). S. 32-38 DOI: 10.1016/j.pan.2015.02.013
Apte M.V., Wilson J.S., Lugea A., Pandol S.J. A starring role for stellate cells in the pancreatic cancer microenvironment//Gastroenterology. 2013. Vol. 144 (6). P. 1210-1219 DOI: 10.1053/j.gastro.2012.11.037
Berchtold S., Grünwald B., Krüger A., Reithmeier A., Hähl T., Cheng T., Feuchtinger A., Born D., Erkan M., Kleeff J., Esposito I. Collagen type V promotes the malignant phenotype of pancreatic ductal adenocarcinoma//Cancer Lett. 2015. Vol. 356 (2 Pt B). P. 721-732 DOI: 10.1016/j.canlet.2014.10.020
Bosco M.C., Puppo M., Blengio F., Fraone T., Cappello P., Giovarelli M., Varesio L. Monocytes and dendritic cells in a hypoxic environment: Spotlights on chemotaxis and migration//Immunobiology. 2008. Vol. 213 (9-10). P. 733-749 DOI: 10.1016/j.imbio.2008.07.031
Brandes F., Schmidt K., Wagner C., Redekopf J., Schlitt H.J., Geissler E.K., Lang S.A. Targeting cMET with INC280 impairs tumour growth and improves efficacy of gemcitabine in a pancreatic cancer model//BMC Cancer. 2015. Vol. 15. P. 71 DOI: 10.1186/s12885-015-1064-9
Brennen W.N., Isaacs J.T., Denmeade S.R. Rationale behind targeting fibroblast activation protein-expressing carcinoma-associated fibroblasts as a novel chemotherapeutic strategy//Mol. Cancer Ther. 2012. Vol. 11 (2). P. 257-266 DOI: 10.1158/1535-7163.MCT-11-0340
Brentnall T.A. Arousal of cancer-associated stromal fibroblasts: palladin-activated fibroblasts promote tumor invasion//Cell Adh. Migr. 2012. Vol. 6 (6). P. 488-494 DOI: 10.4161/cam.21453
Buscail L., Bournet B., Dufresne M., Torrisani J., Cordelier P. Advance in the biology of pancreatic of cancer//Bull. Cancer. 2015. Vol. 102 (6 Suppl 1). S53-61 DOI: 10.1016/S0007-4551(15)31218-2
CasazzaA., Laoui D., Wenes M., Rizzolio S., Bassani N., Mambretti M., Deschoemaeker S., Van Ginderachter J.A., Tamagnone L., Mazzone M. Impeding macrophage entry into hypoxic tumor areas by Sema3A/Nrp1 signaling blockade inhibits angiogenesis and restores antitumor immunity//Cancer Cell. 2013. Vol. 24 (6). P. 695-709. doi: 10.1016/j. ccr.2013.11.007
Cid-Arregui A., Juarez V. Perspectives in the treatment of pancreatic adenocarcinoma//World J. Gastroenterol. 2015. Vol. 21 (31). P. 9297-9316 DOI: 10.3748/wjg.v21.i31.9297
Chiorean E.G., Coveler A.L. Pancreatic cancer: optimizing treatment options, new, and emerging targeted therapies//Drug Des. Devel. Ther. 2015. Vol. 9. P. 3529-3545 DOI: 10.2147/DDDT.S60328
Cohen R., Neuzillet C., Tijeras-Raballand A., Faivre S., de Gramont A., Raymond E. Targeting cancer cell metabolism in pancreatic adenocarcinoma//Oncotarget. 2015. Vol. 6 (19). P. 16832-16847
Coleman S.J., Chioni A.M., Ghallab M.,Anderson R.K., Lemoine N.R., Kocher H.M., Grose R.P. Nuclear translocation of FGFR1 and FGF2 in pancreatic stellate cells facilitates pancreatic cancer cell invasion//EMBO Mol. Med. 2014. Vol. 6 (4). P. 467-481. doi: 10.1002/em-mm.201302698
Dangi-Garimella S., Sahai V., Ebine K., Kumar K., Munshi H.G. Threedimensional collagen I promotes gemcitabine resistance in vitro in pancreatic cancer cells through HMGA2-dependent histone acetyltransferase expression//PLoS One. 2013. Vol. 8 (5):e64566. doi: 10.1371/journal.pone.0064566
Delitto D., Vertes-George E., Hughes S.J., Behrns K.E., Trevino J.G. C-Met signaling in the development of tumorigenesis and chemoresistance: potential applications in pancreatic cancer//World J. Gastroenterol. 2014. Vol. 20 (26). P. 8458-8470 DOI: 10.3748/wjg.v20.i26.8458
Drifka C.R., Tod J., Loeffler A.G., Liu Y., Thomas G.J., Eliceiri K.W., Kao W.J. Periductal stromal collagen topology of pancreatic ductal adenocarcinoma differs from that of normal and chronic pancreatitis//Mod. Pathol. 2015. Vol. 28 (11). P. 1470-1480. doi: 10.1038/modpathol.2015.97
Erkan M., Kleeff J., Gorbachevski A., Reiser C., Mitkus T., Esposito I., Giese T., Büchler M.W., Giese N.A., Friess H. Periostin creates a tumorsupportive microenvironment in the pancreas by sustaining fibrogenic stellate cell activity//Gastroenterology. 2007. Vol. 132 (4). P. 1447-1464
Feig C., Gopinathan A., Neesse A., Chan D.S., Cook N., Tuveson D.A. The pancreas cancer microenvironment//Clin. Cancer Res. 2012. Vol. 18 (16). P. 4266-4276 DOI: 10.1158/1078-0432.CCR-11-3114
Garajová I., Le Large T.Y., Frampton A.E., Rolfo C., Voortman J., Giovannetti E. Molecular mechanisms underlying the role of microRNAs in the chemoresistance of pancreatic cancer//Biomed. Res. Int. 2014: 678401 DOI: 10.1155/2014/678401
Gardian K., Janczewska S., Olszewski W.L., Durlik M. Analysis of pancreatic cancer microenvironment: role of macrophage infiltrates and growth factors expression//J. Cancer. 2012. Vol. 3. P. 285-291 DOI: 10.7150/jca.4537
Hwang R.F., Moore T., Arumugam T., Ramachandran V., Amos K.D., Rivera A, Ji B., Evans D.B., Logsdon C.D. Cancer-associated stromal fibroblasts promote pancreatic tumor progression//Cancer Res. 2008. Vol. 68 (3). P. 918-926 DOI: 10.1158/0008-5472.CAN-07-5714
Hu H., Jiao F., Han T., Wang L.W. Functional significance of macrophages in pancreatic cancer biology//Tumour Biol. 2015. doi:10.1007/s13277-015-4127-2
Infante J.R., Matsubayashi H., Sato N., Tonascia J., Klein A.P., Riall T.A., Yeo C, Iacobuzio-Donahue C., Goggins M. Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma//J. Clin Oncol. 2007. Vol. 25 (3). P. 319-325
Ino Y., Yamazaki-Itoh R., Shimada K., Iwasaki M., Kosuge T., Kanai Y., Hiraoka N. Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer//Br. J. Cancer. 2013. Vol. 108 (4). P. 914-923 DOI: 10.1038/bjc.2013.32
Jacob M., Chang L., Puré E. Fibroblast activation protein in remodeling tissues//Curr. Mol. Med. 2012. Vol. (10). P. 1220-1243
Jacobetz M.A., Chan D.S., Neesse A., Bapiro T.E., Cook N., Frese K.K., Feig C., Nakagawa T., Caldwell M.E., Zecchini H.I., Lolkema M.P., Jiang P., Kultti A., Thompson C.B., Maneval D.C., Jodrell D.I., Frost G.I., Shepard H.M., Skepper J.N., Tuveson D.A. Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer//Gut. 2013. Vol. 62 (1). P. 112-120 DOI: 10.1136/gutjnl-2012-302529
Kawase T., Yasui Y., Nishina S., Hara Y., Yanatori I., Tomiyama Y., Nakashima Y., Yoshida K., Kishi F., Nakamura M., Hino K. Fibroblast activation protein-α-expressing fibroblasts promote the progression of pancreatic ductal adenocarcinoma//BMC Gastroenterol. 2015. Vol. 15 (1). P. 109 DOI: 10.1186/s12876-015-0340-0
Lee H.O., Mullins S.R., Franco-Barraza J., Valianou M., Cukierman E., Cheng J.D. FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells//BMC Cancer. 2011. Vol. 11. P. 245 DOI: 10.1186/1471-2407-11-245
Liu C., Yu S., Zinn K., Wang J., Zhang L., Jia Y., Kappes J.C., Barnes S., Kimberly R.P., Grizzle W.E., Zhang H.G. Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function//J. Immunol. 2006. Vol. 176 (3). P. 1375-1385
Liu Y., Du L. Role of pancreatic stellate cells and periostin in pancreatic cancer progression//Tumour Biol. 2015. Vol. 36 (5). P. 3171-3177 DOI: 10.1007/s13277-015-3386-2
Masamune A., Shimosegawa T. Pancreatic stellate cells: Adynamic player of the intercellular communication in pancreatic cancer//Clin. Res. Hepatol. Gastroenterol. 2015. Vol. 39 (Suppl. 1). S. 98-103. doi: 10.1016/j. clinre.2015.05.018
Mews P., Phillips P., Fahmy R., Korsten M., Pirola R., Wilson J., Apte M. Pancreatic stellate cells respond to inflammatory cytokines: potential role in chronic pancreatitis//Gut. 2002. Vol. 50 (4). P. 535-541
Mielgo A., Schmid M.C. Impact of tumour associated macrophages in pancreatic cancer//BMB Rep. 2013. Vol. 46 (3). P. 131-138
Nakamura T., Mizuno S. The discovery of hepatocyte growth factor (HGF) and its significance for cell biology, life sciences and clinical medicine//Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 2010. Vol. 86 (6). P. 588-610
Neesse A., Algül H., Tuveson D.A., Gress T.M. Stromal biology and therapy in pancreatic cancer: a changing paradigm//Gut. 2015. Vol. 64 (9). P. 1476-1484 DOI: 10.1136/gutjnl-2015-309304
Neuzillet C., Tijeras-Raballand A., Cros J., Faivre S., Hammel P., Raymond E. Stromal expression of SPARC in pancreatic adenocarcinoma//Cancer Metastasis Rev. 2013. Vol. 32 (3-4). P. 585-602. doi: 10.1007/s10555-013-9439-3
Ninichuk V., Gross O., Reichel C., Khandoga A., Pawar R.D., Ciubar R., Segerer S., Belemezova E., Radomska E., Luckow B., Perez de Lema G., Murphy P.M., Gao J.L., Henger A., Kretzler M., Horuk R., Weber M., Krombach F., Schlöndorff D., Anders H.J. Delayed chemokine receptor 1 blockade prolongs survival in collagen 4A3-deficient mice with Alport disease//J. Am. Soc. Nephrol. 2005. Vol. 16 (4). P. 977-985
Özdemir B.C., Pentcheva-Hoang T., Carstens J.L., Zheng X., Wu C.C., Simpson T.R., Laklai H., Sugimoto H., Kahlert C., Novitskiy S.V., De Jesus-Acosta A., Sharma P., Heidari P., Mahmood U., Chin L., Moses H.L., Weaver V.M., Maitra A., Allison J.P., LeBleu V.S., Kalluri R. Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival//Cancer Cell. 2014. Vol. 25 (6). P. 719-734 DOI: 10.1016/j.ccr.2014.04.005
Pan B., Liao Q., Niu Z., Zhou L., Zhao Y. Cancer-associated fibroblasts in pancreatic adenocarcinoma//Future Oncol. 2015. Vol. 11 (18). P. 2603-2610 DOI: 10.2217/FON.15.176
Pang W., Su J., Wang Y., Feng H., Dai X., Yuan Y., Chen X., Yao W. Pancreatic cancer-secreted miR-155 implicates in the conversion from normal fibroblasts to cancer-associated fibroblasts//Cancer Sci. 2015. Vol. 106 (10). P. 1362-1369 DOI: 10.1111/cas.12747
Qian L.W., Mizumoto K., Maehara N., Ohuchida K., Inadome N., Saimura M., Nagai E., Matsumoto K., Nakamura T., Tanaka M. Co-cultivation of pancreatic cancer cells with orthotopic tumor-derived fibroblasts: fibroblasts stimulate tumor cell invasion via HGF secretion whereas cancer cells exert a minor regulative effect on fibroblasts HGF production//Cancer Lett. 2003. Vol. 190 (1). P. 105-112
Rhim A.D., Oberstein P.E., Thomas D.H., Mirek E.T., Palermo C.F., Sastra S.A., Dekleva E.N., Saunders T., Becerra C.P., Tattersall I.W., Westphalen C.B., Kitajewski J., Fernandez-Barrena M.G., Fernandez-Zapico M.E., Iacobuzio-Donahue C., Olive K.P., Stanger B.Z. Stromal elementsact to restrain, rather than support, pancreatic ductal adenocarcinoma//Cancer Cell. 2014. Vol. 25 (6). P. 735-747 DOI: 10.1016/j.ccr.2014.04.021
Rizwani W., Allen A.E., Trevino J.G. Hepatocyte growth factor from a clinical perspective: a pancreatic cancer challenge//Cancers (Basel). 2015. Vol. 7 (3). P. 1785-1805
Rucki A.A., Zheng L. Pancreatic cancer stroma: Understanding biology leads to new therapeutic strategies//World J. Gastroenterol. 2014. Vol. 20 (9). P. 2237-2246 DOI: 10.3748/wjg.v20.i9.2237
Sato N., Maehara N., Goggins M. Gene expression profiling of tumor-stromal interactions between pancreatic cancer cells and stromal fibroblasts. Cancer Res. 2004. Vol. 64 (19). P. 6950-6956
Schmid-Kotsas A., Gross H.J., Menke A., Weidenbach H., Adler G., Siech M., Beger H., Grünert A., Bachem M.G. Lipopolysaccharide-activated macrophages stimulate the synthesis of collagen type I and C-fibronectin in cultured pancreatic stellate cells//Am. J. Pathol. 1999. Vol. 155 (5). P. 1749-1758
Sherman M.H., Yu R.T., Engle D.D., Ding N., Atkins A.R., Tiriac H., Collisson E.A., Connor F., Van Dyke T., Kozlov S., Martin P., Tseng T.W., Dawson D.W., Donahue T.R., Masamune A., Shimosegawa T., Apte M.V., Wilson J.S., Ng B., Lau S.L., Gunton J.E., Wahl G.M., Hunter T., Drebin J.A., O’Dwyer P.J., Liddle C., Tuveson D.A., Downes M., Evans R.M. Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy//Cell. 2014. Vol. 159 (1). P. 80-93 DOI: 10.1016/j.cell.2014.08.007
Shi M., Yu D.H., Chen Y., Zhao C.Y., Zhang J., Liu Q.H., Ni C.R., Zhu M.H. Expression of fibroblast activation protein in human pancreatic adenocarcinoma and its clinicopathological significance//World J. Gastroenterol. 2012. Vol. 18 (8). P. 840-846 DOI: 10.3748/wjg.v18.i8.840
Sinn M., Sinn B.V., Striefler J.K., Lindner J.L., Stieler J.M., Lohneis P., Bischoff S., Bläker H., Pelzer U., Bahra M., Dietel M., Dörken B., Oettle H., Riess H., Denkert C. SPARC expression in resected pancreatic cancer patients treated with gemcitabine: results from the CONKO-001 study//Ann. Oncol. 2014 Vol. 25 (5). P. 1025-1032. doi: 10.1093/annonc/mdu084
Sugimoto M., Mitsunaga S., Yoshikawa K., Kato Y., Gotohda N., Takahashi S., Konishi M., Ikeda M., Kojima M., Ochiai A., Kaneko H. Prognostic impact of M2 macrophages at neural invasion in patients with invasive ductal carcinoma of the pancreas//Eur. J. Cancer. 2014. Vol. 50 (11). P. 1900-1908 DOI: 10.1016/j.ejca.2014.04.010
Tang Y., Xu X., Guo S., Zhang C., Tang Y., Tian Y., Ni B., Lu B., Wang H. An increased abundance of tumor-infiltrating regulatory T cells is correlated with the progression and prognosis of pancreatic ductal adenocarcinoma//PLoS One. 2014. Vol. 9 (3): e91551. doi: 10.1371/journal.pone.0091551
Vonlaufen A., Joshi S., Qu C., Phillips P.A., Xu Z., Parker N.R., Toi C.S., Pirola R.C., Wilson J.S., Goldstein D., Apte M.V. Pancreatic stellate cells: partners in crime with pancreatic cancer cells//Cancer Res. 2008. Vol. 68 (7). P. 2085-2093 DOI: 10.1158/0008-5472.CAN-07-2477
Wang K., Tang J. Tumour-derived exosomes and their roles in cancer//Zhong Nan Da XueXueBao Yi Xue Ban. 2010. Vol. 35 (12). P. 1288-1292 DOI: 10.3969/j.issn.1672-7347.2010.12.015
Whatcott C.J., Diep CH, Jiang P, Watanabe A., LoBello J., Sima C., Hostetter G., Shepard H.M., Von Hoff D.D., Han H. Desmoplasia in primary tumors and metastatic lesions of pancreatic cancer//Clin. Cancer Res. 2015. Vol. 21 (15). P. 3561-3568. CCR-14-1051 DOI: 10.1158/1078-0432
Xu Z., Pothula S.P., Wilson J.S., Apte M.V. Pancreatic cancer and its stroma: A conspiracy theory//World J. Gastroenterol. 2014. Vol.20 (32). P. 11216-11229 DOI: 10.3748/wjg.v20.i32.11216
Brennen W.N., Isaacs J.T., Denmeade S.R. Rationale behind targeting fibroblast activation protein-expressing carcinoma-associated fibroblasts as a novel chemotherapeutic strategy//Mol. Cancer Ther. 2012. Vol. 11 (2). P. 257-266 DOI: 10.1158/1535-7163.MCT-11-0340
Brentnall T.A. Arousal of cancer-associated stromal fibroblasts: palladin-activated fibroblasts promote tumor invasion//Cell Adh. Migr. 2012. Vol. 6 (6). P. 488-494 DOI: 10.4161/cam.21453
Buscail L., Bournet B., Dufresne M., Torrisani J., Cordelier P. Advance in the biology of pancreatic of cancer//Bull. Cancer. 2015. Vol. 102 (6 Suppl 1). S53-61 DOI: 10.1016/S0007-4551(15)31218-2
CasazzaA., Laoui D., Wenes M., Rizzolio S., Bassani N., Mambretti M., Deschoemaeker S., Van Ginderachter J.A., Tamagnone L., Mazzone M. Impeding macrophage entry into hypoxic tumor areas by Sema3A/Nrp1 signaling blockade inhibits angiogenesis and restores antitumor immunity//Cancer Cell. 2013. Vol. 24 (6). P. 695-709. doi: 10.1016/j. ccr.2013.11.007
Cid-Arregui A., Juarez V. Perspectives in the treatment of pancreatic adenocarcinoma//World J. Gastroenterol. 2015. Vol. 21 (31). P. 9297-9316 DOI: 10.3748/wjg.v21.i31.9297
Chiorean E.G., Coveler A.L. Pancreatic cancer: optimizing treatment options, new, and emerging targeted therapies//Drug Des. Devel. Ther. 2015. Vol. 9. P. 3529-3545 DOI: 10.2147/DDDT.S60328
Cohen R., Neuzillet C., Tijeras-Raballand A., Faivre S., de Gramont A., Raymond E. Targeting cancer cell metabolism in pancreatic adenocarcinoma//Oncotarget. 2015. Vol. 6 (19). P. 16832-16847
Coleman S.J., Chioni A.M., Ghallab M.,Anderson R.K., Lemoine N.R., Kocher H.M., Grose R.P. Nuclear translocation of FGFR1 and FGF2 in pancreatic stellate cells facilitates pancreatic cancer cell invasion//EMBO Mol. Med. 2014. Vol. 6 (4). P. 467-481. doi: 10.1002/em-mm.201302698
Dangi-Garimella S., Sahai V., Ebine K., Kumar K., Munshi H.G. Threedimensional collagen I promotes gemcitabine resistance in vitro in pancreatic cancer cells through HMGA2-dependent histone acetyltransferase expression//PLoS One. 2013. Vol. 8 (5):e64566. doi: 10.1371/journal.pone.0064566
Delitto D., Vertes-George E., Hughes S.J., Behrns K.E., Trevino J.G. C-Met signaling in the development of tumorigenesis and chemoresistance: potential applications in pancreatic cancer//World J. Gastroenterol. 2014. Vol. 20 (26). P. 8458-8470 DOI: 10.3748/wjg.v20.i26.8458
Drifka C.R., Tod J., Loeffler A.G., Liu Y., Thomas G.J., Eliceiri K.W., Kao W.J. Periductal stromal collagen topology of pancreatic ductal adenocarcinoma differs from that of normal and chronic pancreatitis//Mod. Pathol. 2015. Vol. 28 (11). P. 1470-1480. doi: 10.1038/modpathol.2015.97
Erkan M., Kleeff J., Gorbachevski A., Reiser C., Mitkus T., Esposito I., Giese T., Büchler M.W., Giese N.A., Friess H. Periostin creates a tumorsupportive microenvironment in the pancreas by sustaining fibrogenic stellate cell activity//Gastroenterology. 2007. Vol. 132 (4). P. 1447-1464
Feig C., Gopinathan A., Neesse A., Chan D.S., Cook N., Tuveson D.A. The pancreas cancer microenvironment//Clin. Cancer Res. 2012. Vol. 18 (16). P. 4266-4276 DOI: 10.1158/1078-0432.CCR-11-3114
Garajová I., Le Large T.Y., Frampton A.E., Rolfo C., Voortman J., Giovannetti E. Molecular mechanisms underlying the role of microRNAs in the chemoresistance of pancreatic cancer//Biomed. Res. Int. 2014: 678401 DOI: 10.1155/2014/678401
Gardian K., Janczewska S., Olszewski W.L., Durlik M. Analysis of pancreatic cancer microenvironment: role of macrophage infiltrates and growth factors expression//J. Cancer. 2012. Vol. 3. P. 285-291 DOI: 10.7150/jca.4537
Hwang R.F., Moore T., Arumugam T., Ramachandran V., Amos K.D., Rivera A, Ji B., Evans D.B., Logsdon C.D. Cancer-associated stromal fibroblasts promote pancreatic tumor progression//Cancer Res. 2008. Vol. 68 (3). P. 918-926 DOI: 10.1158/0008-5472.CAN-07-5714
Hu H., Jiao F., Han T., Wang L.W. Functional significance of macrophages in pancreatic cancer biology//Tumour Biol. 2015. doi:10.1007/s13277-015-4127-2
Infante J.R., Matsubayashi H., Sato N., Tonascia J., Klein A.P., Riall T.A., Yeo C, Iacobuzio-Donahue C., Goggins M. Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma//J. Clin Oncol. 2007. Vol. 25 (3). P. 319-325
Ino Y., Yamazaki-Itoh R., Shimada K., Iwasaki M., Kosuge T., Kanai Y., Hiraoka N. Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer//Br. J. Cancer. 2013. Vol. 108 (4). P. 914-923 DOI: 10.1038/bjc.2013.32
Jacob M., Chang L., Puré E. Fibroblast activation protein in remodeling tissues//Curr. Mol. Med. 2012. Vol. (10). P. 1220-1243
Jacobetz M.A., Chan D.S., Neesse A., Bapiro T.E., Cook N., Frese K.K., Feig C., Nakagawa T., Caldwell M.E., Zecchini H.I., Lolkema M.P., Jiang P., Kultti A., Thompson C.B., Maneval D.C., Jodrell D.I., Frost G.I., Shepard H.M., Skepper J.N., Tuveson D.A. Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer//Gut. 2013. Vol. 62 (1). P. 112-120 DOI: 10.1136/gutjnl-2012-302529
Kawase T., Yasui Y., Nishina S., Hara Y., Yanatori I., Tomiyama Y., Nakashima Y., Yoshida K., Kishi F., Nakamura M., Hino K. Fibroblast activation protein-α-expressing fibroblasts promote the progression of pancreatic ductal adenocarcinoma//BMC Gastroenterol. 2015. Vol. 15 (1). P. 109 DOI: 10.1186/s12876-015-0340-0
Lee H.O., Mullins S.R., Franco-Barraza J., Valianou M., Cukierman E., Cheng J.D. FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells//BMC Cancer. 2011. Vol. 11. P. 245 DOI: 10.1186/1471-2407-11-245
Liu C., Yu S., Zinn K., Wang J., Zhang L., Jia Y., Kappes J.C., Barnes S., Kimberly R.P., Grizzle W.E., Zhang H.G. Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function//J. Immunol. 2006. Vol. 176 (3). P. 1375-1385
Liu Y., Du L. Role of pancreatic stellate cells and periostin in pancreatic cancer progression//Tumour Biol. 2015. Vol. 36 (5). P. 3171-3177 DOI: 10.1007/s13277-015-3386-2
Masamune A., Shimosegawa T. Pancreatic stellate cells: Adynamic player of the intercellular communication in pancreatic cancer//Clin. Res. Hepatol. Gastroenterol. 2015. Vol. 39 (Suppl. 1). S. 98-103. doi: 10.1016/j. clinre.2015.05.018
Mews P., Phillips P., Fahmy R., Korsten M., Pirola R., Wilson J., Apte M. Pancreatic stellate cells respond to inflammatory cytokines: potential role in chronic pancreatitis//Gut. 2002. Vol. 50 (4). P. 535-541
Mielgo A., Schmid M.C. Impact of tumour associated macrophages in pancreatic cancer//BMB Rep. 2013. Vol. 46 (3). P. 131-138
Nakamura T., Mizuno S. The discovery of hepatocyte growth factor (HGF) and its significance for cell biology, life sciences and clinical medicine//Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 2010. Vol. 86 (6). P. 588-610
Neesse A., Algül H., Tuveson D.A., Gress T.M. Stromal biology and therapy in pancreatic cancer: a changing paradigm//Gut. 2015. Vol. 64 (9). P. 1476-1484 DOI: 10.1136/gutjnl-2015-309304
Neuzillet C., Tijeras-Raballand A., Cros J., Faivre S., Hammel P., Raymond E. Stromal expression of SPARC in pancreatic adenocarcinoma//Cancer Metastasis Rev. 2013. Vol. 32 (3-4). P. 585-602. doi: 10.1007/s10555-013-9439-3
Ninichuk V., Gross O., Reichel C., Khandoga A., Pawar R.D., Ciubar R., Segerer S., Belemezova E., Radomska E., Luckow B., Perez de Lema G., Murphy P.M., Gao J.L., Henger A., Kretzler M., Horuk R., Weber M., Krombach F., Schlöndorff D., Anders H.J. Delayed chemokine receptor 1 blockade prolongs survival in collagen 4A3-deficient mice with Alport disease//J. Am. Soc. Nephrol. 2005. Vol. 16 (4). P. 977-985
Özdemir B.C., Pentcheva-Hoang T., Carstens J.L., Zheng X., Wu C.C., Simpson T.R., Laklai H., Sugimoto H., Kahlert C., Novitskiy S.V., De Jesus-Acosta A., Sharma P., Heidari P., Mahmood U., Chin L., Moses H.L., Weaver V.M., Maitra A., Allison J.P., LeBleu V.S., Kalluri R. Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival//Cancer Cell. 2014. Vol. 25 (6). P. 719-734 DOI: 10.1016/j.ccr.2014.04.005
Pan B., Liao Q., Niu Z., Zhou L., Zhao Y. Cancer-associated fibroblasts in pancreatic adenocarcinoma//Future Oncol. 2015. Vol. 11 (18). P. 2603-2610 DOI: 10.2217/FON.15.176
Pang W., Su J., Wang Y., Feng H., Dai X., Yuan Y., Chen X., Yao W. Pancreatic cancer-secreted miR-155 implicates in the conversion from normal fibroblasts to cancer-associated fibroblasts//Cancer Sci. 2015. Vol. 106 (10). P. 1362-1369 DOI: 10.1111/cas.12747
Qian L.W., Mizumoto K., Maehara N., Ohuchida K., Inadome N., Saimura M., Nagai E., Matsumoto K., Nakamura T., Tanaka M. Co-cultivation of pancreatic cancer cells with orthotopic tumor-derived fibroblasts: fibroblasts stimulate tumor cell invasion via HGF secretion whereas cancer cells exert a minor regulative effect on fibroblasts HGF production//Cancer Lett. 2003. Vol. 190 (1). P. 105-112
Rhim A.D., Oberstein P.E., Thomas D.H., Mirek E.T., Palermo C.F., Sastra S.A., Dekleva E.N., Saunders T., Becerra C.P., Tattersall I.W., Westphalen C.B., Kitajewski J., Fernandez-Barrena M.G., Fernandez-Zapico M.E., Iacobuzio-Donahue C., Olive K.P., Stanger B.Z. Stromal elementsact to restrain, rather than support, pancreatic ductal adenocarcinoma//Cancer Cell. 2014. Vol. 25 (6). P. 735-747 DOI: 10.1016/j.ccr.2014.04.021
Rizwani W., Allen A.E., Trevino J.G. Hepatocyte growth factor from a clinical perspective: a pancreatic cancer challenge//Cancers (Basel). 2015. Vol. 7 (3). P. 1785-1805
Rucki A.A., Zheng L. Pancreatic cancer stroma: Understanding biology leads to new therapeutic strategies//World J. Gastroenterol. 2014. Vol. 20 (9). P. 2237-2246 DOI: 10.3748/wjg.v20.i9.2237
Sato N., Maehara N., Goggins M. Gene expression profiling of tumor-stromal interactions between pancreatic cancer cells and stromal fibroblasts. Cancer Res. 2004. Vol. 64 (19). P. 6950-6956
Schmid-Kotsas A., Gross H.J., Menke A., Weidenbach H., Adler G., Siech M., Beger H., Grünert A., Bachem M.G. Lipopolysaccharide-activated macrophages stimulate the synthesis of collagen type I and C-fibronectin in cultured pancreatic stellate cells//Am. J. Pathol. 1999. Vol. 155 (5). P. 1749-1758
Sherman M.H., Yu R.T., Engle D.D., Ding N., Atkins A.R., Tiriac H., Collisson E.A., Connor F., Van Dyke T., Kozlov S., Martin P., Tseng T.W., Dawson D.W., Donahue T.R., Masamune A., Shimosegawa T., Apte M.V., Wilson J.S., Ng B., Lau S.L., Gunton J.E., Wahl G.M., Hunter T., Drebin J.A., O’Dwyer P.J., Liddle C., Tuveson D.A., Downes M., Evans R.M. Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy//Cell. 2014. Vol. 159 (1). P. 80-93 DOI: 10.1016/j.cell.2014.08.007
Shi M., Yu D.H., Chen Y., Zhao C.Y., Zhang J., Liu Q.H., Ni C.R., Zhu M.H. Expression of fibroblast activation protein in human pancreatic adenocarcinoma and its clinicopathological significance//World J. Gastroenterol. 2012. Vol. 18 (8). P. 840-846 DOI: 10.3748/wjg.v18.i8.840
Sinn M., Sinn B.V., Striefler J.K., Lindner J.L., Stieler J.M., Lohneis P., Bischoff S., Bläker H., Pelzer U., Bahra M., Dietel M., Dörken B., Oettle H., Riess H., Denkert C. SPARC expression in resected pancreatic cancer patients treated with gemcitabine: results from the CONKO-001 study//Ann. Oncol. 2014 Vol. 25 (5). P. 1025-1032. doi: 10.1093/annonc/mdu084
Sugimoto M., Mitsunaga S., Yoshikawa K., Kato Y., Gotohda N., Takahashi S., Konishi M., Ikeda M., Kojima M., Ochiai A., Kaneko H. Prognostic impact of M2 macrophages at neural invasion in patients with invasive ductal carcinoma of the pancreas//Eur. J. Cancer. 2014. Vol. 50 (11). P. 1900-1908 DOI: 10.1016/j.ejca.2014.04.010
Tang Y., Xu X., Guo S., Zhang C., Tang Y., Tian Y., Ni B., Lu B., Wang H. An increased abundance of tumor-infiltrating regulatory T cells is correlated with the progression and prognosis of pancreatic ductal adenocarcinoma//PLoS One. 2014. Vol. 9 (3): e91551. doi: 10.1371/journal.pone.0091551
Vonlaufen A., Joshi S., Qu C., Phillips P.A., Xu Z., Parker N.R., Toi C.S., Pirola R.C., Wilson J.S., Goldstein D., Apte M.V. Pancreatic stellate cells: partners in crime with pancreatic cancer cells//Cancer Res. 2008. Vol. 68 (7). P. 2085-2093 DOI: 10.1158/0008-5472.CAN-07-2477
Wang K., Tang J. Tumour-derived exosomes and their roles in cancer//Zhong Nan Da XueXueBao Yi Xue Ban. 2010. Vol. 35 (12). P. 1288-1292 DOI: 10.3969/j.issn.1672-7347.2010.12.015
Whatcott C.J., Diep CH, Jiang P, Watanabe A., LoBello J., Sima C., Hostetter G., Shepard H.M., Von Hoff D.D., Han H. Desmoplasia in primary tumors and metastatic lesions of pancreatic cancer//Clin. Cancer Res. 2015. Vol. 21 (15). P. 3561-3568. CCR-14-1051 DOI: 10.1158/1078-0432
Xu Z., Pothula S.P., Wilson J.S., Apte M.V. Pancreatic cancer and its stroma: A conspiracy theory//World J. Gastroenterol. 2014. Vol.20 (32). P. 11216-11229 DOI: 10.3748/wjg.v20.i32.11216

Еще

Статья научная